Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CBO's Advisors

This article was originally published in RPM Report

Executive Summary

The Congressional Budget Office will take on heightened importance in 2009 as health care reform becomes a domestic policy priority. Finding meaningful, scorable savings will be imperative in order to move legislation. With that, CBO’s panel of health advisors, a group of outside health care experts who meet periodically to provide guidance to the agency, will take on an increasingly important role.

You may also be interested in...

The Value of Options: CBO Health Reform Pre-Scores Draw Yawn From Wall Street

The Congressional Budget Office released a book of budget options on over 100 single health reform proposals. Analysts say it’s too early for them to start paying attention. But if recent history provides any lesson, it’s that how CBO scores health reform matters greatly to its overall legislative prospects—and the impact on Wall Street.

Bookends for Reform

The boundaries of the health care reform debate for 2009 are evident in a bipartisan coalition of four senators (two Democrats and two Republicans) who have identified some of the fundamental components of any successful reform effort. Moving the access point for primary care out of the emergency rooms is one of the fundamentals.

US FDA Communication Ahead Of Major Actions Could Counter Misinformation, Ex-Official Says

Instead of waiting until after regulatory events like COVID boosters and Aduhelm, FDA should describe its decision-making process along the way to help restore public faith in the agency, former deputy commissioner Josh Sharfstein says.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts